FireLady's MS Index Page
FATIGUE, DIGGING FOR CLUES
 
If you have information that you would like to see here, please contact me at: FireLady40@aol.com. 
 
Return to Articles Index
Return to MS IndexReturn to Home Page
 

FATIGUE, DIGGING FOR CLUES
Copyright 1995 National Multiple Sclerosis Society
 
UNDERSTANDING TYPES OF FATIGUE
MANAGING FATIGUE 
General Guidelines 
SPECIFIC SUGGESTIONS
Dr. Lauren Krupp is working on a provocative idea shared by
other scientists in her field: that there is some immune or neuroendocrine
abnormality caused by multiple sclerosis that explains the overwhelming
fatigue that afflicts 80 to 90 percent of people with MS.

The Society grantee, who is associate professor of neurology at the State
University of New York at Stony Brook, hopes ultimately to find biochemical
changes in the blood or an alteration in the immune response that can match
up with a patient's degree of fatigue.

What is so special about MS fatigue?  Dr. Krupp defines it as "a sense of
tiredness, a lack of energy, really a total body give-out.  It's not
weakness; instead, it's a generalized low-energy feeling.  The fatigue is not
related to depression.

Almost all patients find their fatigue gets much worse on a hot and humid
day; and many people say the fatigue makes other MS symptoms worse."

Dr. Krupp and her co-workers have compared MS fatigue with fatigue in people
with systemic lupus erythematosus (SLE) and other medical illnesses, and
healthy controls.  They found MS fatigue had a harmful impact on daily living
and was greatly worsened by heat.

Dr. Krupp's extensive interviews showed that fatigue results in loss of
patience and lowering of motivation for healthy people and people with MS
alike.

Some things that help healthy people -sresting, sleeping, positive
experiences - work well for people with MS too.  Things that worsen fatigue -
stress, physical activity, the late-afternoon doldrums - also have the same
effect on both groups.

The small proportion of people with MS who don't suffer from MS fatigue
seemed to answer Dr. Krupp's questions in the same way healthy people did.
The feature that sharply distinguished MS fatigue was the impact it had on
activities of daily living.

"With healthy people, fatigue does not interfere with social, family or
professional responsibilities," the clinician commented.  "In contrast, 67
percent of MS patients said that fatigue alone prevented them from meeting
their responsibilities.  Some 89 percent said that fatigue alone prevented
sustained physical activities."

Some doctors unfamiliar with MS may ascribe patients' fatigue to depression,
Dr. Krupp says.  But she found otherwise.  "We looked at the question in a
statistical way, trying to see how well fatigue matched depression.

That is, if somebody with MS was very depressed, was that a good indicator of
fatigue?  Or if someone was not depressed at all, would that mean there was
no fatigue?"  It turns out neither one correlates strongly with the other: MS
fatigue may overlap with depression but it is clearly a different symptom.

Recently a multicenter study compared the nervous system stimulant pemoline
(Cylert) with an antiviral drug called amantadine (Symmetrel) and an inert
dummy pill_a "placebo".  Almost all the people studied reported less fatigue,
including those who took the placebo.

However, the group treated with amantadine had a somewhat greater fatigue
reduction than the placebo group.  Both drugs were very well tolerated and
caused few side effects.

The study concluded that more effective fatigue treatments need to be
identified, but, in the meantime, both pemoline and amantadine are reasonable
drug therapies.  Still, only amantadine appeared to be superior to a placebo.

The study also concluded that in MS, problems with mood and cognitive
function are not related to fatigue.  With the help of Drs. David Masur and
Martin Sliwinski at Albert Einstein College of Medicine, Bronx, N.Y., the
investigators found that changes in fatigue levels were not associated with
changes in mood or cognitive functioning.

Fatigue must be viewed as a separate symptom, which might overlap with other
MS symptoms but is essentially a distinct entity.

Dr. Krupp and Dr. Patricia Coyle are working on measurements of cytokines and
immune complexes in blood and spinal fluids to see if these substances, which
indicate immune system activity, can be correlated with MS fatigue.

"Until we can relate such measurements to the fatigue people experience, we
are missing part of the equation," Dr. Krupp says.

Immune studies are still in progress at Stony Brook.  Ultimately, Dr. Krupp
and her colleagues hope to combine findings in neurological, psychological,
and immunological research to develop greater understanding and more
effective approaches to relieving or preventing this major MS symptom.



Back to top
UNDERSTANDING TYPES OF FATIGUE

(Reprinted from "Symptom Management in Multiple Sclerosis", 2nd Edition, by
Randall T. Schapiro, M.D., c1994 Demos Publications, New York.)

Fatigue is one of the most common problems for people with MS.  It is a
difficult problem for others to understand, since it is not manifested by a
highly visible symptom.

However, it can often be treated once its cause has been determined.  Four
specific types of fatigue are seen in MS, and sometimes more than one type is
found in a single individual:

 - Fatigue #1 is the tired feeling that everyone has after working hard.  It
is a natural type of fatigue and implies a good day's work rather than
anything negative medically.  Obviously a good night's rest is the solution
to managing this normal type of fatigue.

 - Fatigue #2 is the "worn out" feeling that occurs when a person is
depressed.  Depression often causes poor appetite, sleep disturbances, and
feelings of poor self-worth.  It is treated with anti-depressant medications
and counseling or therapy.

 - Fatigue #3 can best be illustrated by visualizing a person with MS who has
a slight limp after walking one block, drags the leg after the second, and
needs to stop after the third.  Fatigue results because the nervous impulses
that control the leg muscles are worked beyond their capacity.  It is called
"short-circuiting" fatigue.  The best way to manage it is to allow for
appropriate rest periods.

 - Fatigue #4 is a lassitude that is unique to MS.  "MS fatigue" is an
overwhelming fatigue that can come at any time of day without warning, so
suddenly that one may in fact fall asleep.  The drug Symmetrel (amantidine)
manages this type of fatigue, although the manner in which it works is not
yet understood.

Stimulants such as Cylert (pemoline) and Ritalin (methylphenidate) may
provide relief, but they may cause difficulty in sleeping.  Prozac
(floroxitane) appears to have excellent anti-fatigue properties without
significant side effects.



Back to top
MANAGING FATIGUE
General Guidelines

Balance activity with rest, and learn to allow time to rest when planning a
day's activities.  Rest means doing nothing at all.  There is a fine line
between pushing to fatigue and stopping before it sets in.  Rest improves
overall endurance and leaves strength for enjoyable activities.



Back to top
SPECIFIC SUGGESTIONS Back to top

Updated from an article in the Fall 1989 issue of INSIDE MS.

SOURCE:  NMSS Information Resource Center and Library. EDUCATION DEPARTMENT,
New York: National Multiple Sclerosis Society, c1995.

SOURCE:  (Reprinted from "Symptom Management in Multiple Sclerosis", 2nd
Edition, by Randall T. Schapiro, M.D., c1994 Demos Publications, New York.)

DISCLAIMER:  The National Multiple Sclerosis Society is proud to be a source
of information about multiple sclerosis.  Our comments are based on
professional advice, published experience and expert opinion, but do not
represent therapeutic recommendation or prescription.

For specific information and advice, consult your personal physician.  To
contact either the Information Resource Center and Library of the NMSS, or
your Local Chapter, call 1-800-FIGHT MS (1-800-344-4867).
 
Transmitted:  95-08-23 17:43:30 EDT